Efficacy of mRNA and Inactivated Whole Virus Vaccines Against COVID-19 in Patients with Chronic Respiratory Diseases.

Int J Chron Obstruct Pulmon Dis · 2023 · PMC9869785 · PMID 36698687

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

The vaccine effectiveness (VE) of at least 2 doses of CoronaVac for preventing symptomatic COVID-19, being hospitalized for COVID-19, and respiratory failure due to COVID-19 was estimated to be 31.7%, 81.1% and 87.2% respectively ( Table 3 ). BNT162b2 reduced the risk of symptomatic COVID-19 with borderline significance at univariate analysis while it was significant at multivariate analysis after adjusting for confounders.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.